
2026-04-08
Kuvura kanseri y'ibihaha hakiri kare mu 2026 bivuga ubuvuzi bugezweho bukoreshwa mu gutahura no gucunga kanseri y'ibihaha mu ntangiriro zayo, bikazamura cyane ubuzima. Uburyo bugezweho mubushinwa no guhuza isi yose ubwenge bwubuhanga (AI) kugirango tumenye hakiri kare, tekinike yo kubaga neza, kuvura intego, hamwe nubudahangarwa. Abarwayi bashaka kuvura kanseri y'ibihaha hakiri kare ubu irashobora kubona porogaramu zipima neza, nka CT yongerewe imbaraga za CT iboneka mubitaro bikuru byabashinwa kumadolari agera kuri $ 25, hamwe nubuvuzi bugezweho buvura ubuvuzi bushingiye kumwirondoro.
Kanseri y'ibihaha ikomeje kuba intandaro y'impfu ziterwa na kanseri ku isi, ariko imiterere ya kuvura kanseri y'ibihaha hakiri kare Yahindutse ku buryo bugaragara mu 2026. Kumenya hakiri kare nifatizo ryubuvuzi bwiza, hamwe nubuhanga bushya butuma abaganga bamenya ibibyimba mbere yuko ibimenyetso bigaragara.
Igisobanuro cya kanseri y'ibihaha hakiri kare ubusanzwe ikubiyemo icyiciro cya mbere n'icyiciro cya II kanseri y'ibihaha itari ntoya (NSCLC), aho ikibyimba giherereye kandi kikaba kitakwirakwiriye mu ngingo za kure. Mu 2026, icyibandwaho ntabwo ari ugukuraho ikibyimba gusa ahubwo ni ukurinda ko byongera kubaho binyuze mu buvuzi bujyanye n’imiterere yihariye y’umurwayi.
Iterambere rya vuba ryatumye bishoboka gufata kanseri y'ibihaha nk'indwara idakira aho kwisuzumisha byica abarwayi benshi. Kwishyira hamwe kwa Gusuzuma AI na kubaga byibuze yagabanije ibihe byo gukira no kuzamura imibereho nyuma yubuvuzi.
Kimwe mu bintu byingenzi byagezweho mu 2026 ni uburyo bwo gukwirakwiza imiterere ya AI muri radiologiya. Izi sisitemu zisesengura ibipimo bisanzwe bya tomografiya (LDCT) scan hamwe nukuri kutigeze kubaho, bikerekana imitwe yoroheje amaso yumuntu ashobora kubura.
Mu Bushinwa, ibitaro nkibitaro bishamikiye kuri kaminuza ya Ningbo byohereje imiterere ya AI yakozwe n’ibigo by’ubushakashatsi nka DAMO Academy. Izi ngero zasesenguye ibihumbi magana ya CT scan, zerekana neza kanseri yo mu ntangiriro na kanseri y'ibihaha ku barwayi bagaragaje ibimenyetso bidafitanye isano.
Iri koranabuhanga ni ingenzi cyane kuri kanseri y'ibihaha, aho imyaka itanu yo kubaho isimbuka ikava munsi ya 10% mugihe cyanyuma ikagera kuri 70% mugihe igaragaye hakiri kare. Ubushobozi bwo gukora iri genzura ku giciro gito cyibiciro gakondo - rimwe na rimwe munsi y $ 25 muri gahunda yicyitegererezo - byatumye abantu bashishikazwa nisi yose muburyo bumwe.
Ubushinwa bwagaragaye nk'ahantu h'isi hose hitaweho kuvura kanseri y'ibihaha, ihuza umubare munini w'abarwayi no gukoresha ikoranabuhanga ryihuse. Inzego nyinshi ziyobora kuvura kanseri y'ibihaha hakiri kare, gutanga ibikoresho byo ku rwego rwisi nubushakashatsi bwambere.
Ibi bitaro biherereye muri Shanghai, ni umutangito w’ubushakashatsi no kuvura kanseri y'ibihaha. Iherutse gutangiza "2026 CACA Kanseri Y ibihaha Kanseri Yuzuye-Igikorwa Cy’ubumenyi Cyamamare," igamije kugeza ku baturage kwirinda, gusuzuma, gusuzuma, kuvura, no gusubiza mu buzima busanzwe abaturage.
Ishami rya onkologiya ry’ibitaro, riyobowe n’inzobere zizwi nka Porofeseri Zhou Caicun, rishimangira ko kanseri y’ibihaha itakiri indwara imwe ahubwo ko ari itsinda ry’indwara zisobanurwa na gen zitandukanye. Iyi filozofiya itwara protocole yabo yihariye.
Nkibitaro byinzobere byindwara ya kanseri, ikigo cya kanseri cya kaminuza ya Fudan Shanghai kiri ku isonga mu guhanga udushya no kubaga amavuriro. Ikigo gifite uruhare runini mu kuvugurura umurongo ngenderwaho w’igihugu, harimo “Igitabo gito gitukura” cyo gucunga kanseri y'ibere n'ibihaha.
Ikigo kizwiho gukurikiza byimazeyo ubuvuzi bushingiye ku bimenyetso mu gihe bwinjiza vuba imiti mishya yo kuvura mu mavuriro. Amatsinda yabo atandukanye yemeza ko umurwayi wese yakira isuzuma ryuzuye ririmo abaganga babaga, abaganga ba oncologue, naba radiologiste.
Amaze kwitabwaho n’amahanga, ibi bitaro byerekana imbaraga za AI mubuvuzi busanzwe. Ikora nk'icyitegererezo cy'icyitegererezo cya DAMO PANDA AI, yerekana uburyo ikoranabuhanga rishobora guca icyuho kiri hagati yubuvuzi bwihariye no kugenzura ubuzima rusange.
Abarwayi hano bungukirwa nakazi keza aho imenyekanisha rya AI ritera isuzuma ryihuse ryinzobere, bakemeza ko nta kimenyetso cyambere cyerekana ububi bwirengagijwe. Iyi moderi iri kwigana mubitaro byinshi byabaturage mu karere.
Ibijyanye n'amafaranga y'ubuvuzi ni impungenge zikomeye ku barwayi ku isi. Muri 2026, imiterere yikiguzi cya kuvura kanseri y'ibihaha hakiri kare biratandukanye cyane bitewe nigihugu, ikoranabuhanga ryakoreshejwe, nicyiciro cyo gutahura.
Uburyo bwa gakondo bwo gusuzuma mubihugu byiburengerazuba burashobora kuba buhenze cyane, akenshi bigura amadorari amagana kuri scan imwe ya CT. Ariko, kwishyira hamwe kwa AI mubushinwa byahungabanije ubu buryo.
Porogaramu y'indege ikoresha AI-yongerewe imbaraga-scan CTs yagabanije ibiciro byo gusuzuma hafi $ 25 USD. Uku kugabanuka gukabije kugerwaho binyuze:
Ubu bushobozi butuma isuzumabumenyi rishoboka rishoboka kuri demokarasi yagutse, birashoboka guhindura umurongo wo gusuzuma ugana mubyiciro byambere aho kwivuza bidatera kandi bidahenze.
Mugihe kwipimisha bimaze kubahendutse, ikiguzi cyo kuvura byimazeyo biterwa nuburyo bwatoranijwe. Surgical resection, igipimo cya zahabu kuri kanseri y'ibihaha hakiri kare, gikubiyemo kuguma mu bitaro, anesteziya, n'amafaranga yo kubaga.
Mu Bushinwa, igiciro cyose cyo kubaga amashusho yatewe na videwo yo kubaga thoracoscopique (VATS) irashobora kuva ku $ 3.000 kugeza ku 8000 $, bikaba biri hasi cyane ugereranije n’uburyo bugereranywa muri Amerika cyangwa mu Burayi. Ibi bikubiyemo kugenzura mbere yo kubaga no kwita kuri nyuma yibikorwa.
Ku barwayi bakeneye imiti ivura, ibiciro biratandukanye ukurikije imiti yakoreshejwe. Imiti gakondo ya chimiotherapie muri rusange ntabwo ihendutse, mugihe imiti mishya igamije kuvura hamwe nubudahangarwa bushobora kubahenze cyane. Nyamara, gahunda yubwishingizi bwigihugu hamwe na politiki yo gutanga amasoko menshi mubushinwa byagabanije cyane amafaranga aturuka mumifuka kuriyi miti igezweho.
| Ibigize | Ikigereranyo cyagereranijwe mu Bushinwa (USD) | Ikigereranyo cyagereranijwe muri Amerika (USD) | Inyandiko |
|---|---|---|---|
| Kugenzura AI-Kuzamura LDCT | $ 25 - $ 60 | $ 300 - $ 800 | Ubushinwa bukoresha AI kugirango isuzume neza. |
| Kubaga TVA (Icyiciro cya mbere) | $ 3.000 - $ 8,000 | $ 20.000 - $ 50.000 + | Harimo kuguma mubitaro nubuvuzi bwibanze. |
| Ubuvuzi bugamije (Ukwezi) | $ 500 - $ 2000 | $ 10,000 - $ 15.000 | Ibiciro biratandukanye bitewe nibiyobyabwenge hamwe nubwishingizi. |
| Immunotherapy (Kuri Cycle) | $ 1.000 - $ 3.000 | $ 12,000 - 20.000 $ | Kugura byinshi bigabanya ibiciro mubushinwa. |
Iyi mbonerahamwe irerekana itandukaniro rikomeye mubukungu bwubuzima. Mugihe ubuvuzi bwiza mubitaro bikuru byabashinwa bihanganye niburengerazuba, inyungu yibiciro irakora kuvura kanseri y'ibihaha hakiri kare birashoboka cyane kubaturage basanzwe.
Intwaro yo kurwanya kanseri y'ibihaha yagutse cyane. Mu 2026, kuvura ntibikiri mu kubaga no kuvura imiti. Suite yimiti isobanutse itanga ibyiringiro no kubibazo bigoye.
Gusobanukirwa na genetike yibibyimba ubu ni igice gisanzwe cyo gusuzuma. Abashoferi nka EGFR, ALK, ROS1, na KRAS bategeka guhitamo imiti.
Igisekuru cya gatatu EGFR tyrosine kinase inhibitor (TKIs) nicyo gipimo cyo kwita kuri EGFR-yahinduwe na NSCLC. Ariko, byanze bikunze birwanya iterambere. Ibimaze kugerwaho bikemura iki kibazo mu buryo butaziguye.
ADCs yerekana ihinduka ryimikorere muri oncology. Izi "bombe zubwenge" zitanga chimiotherapie ikomeye mumasemburo ya kanseri, irinda ingirabuzimafatizo nziza. Muri 2026, ADCs yibasira TROP2 yerekanye imikorere idasanzwe kubarwayi bateye imbere kuri EGFR-TKIs.
Igeragezwa rya Clinical, nk'ubushakashatsi bwa OptiTROP-Lung04 riyobowe n'abashakashatsi b'Abashinwa, ryerekanye ko ADC iyobowe na TROP2 ishobora kwagura ubuzima butagira amajyambere ugereranije na chimiotherapie isanzwe. Ibi byashyizeho urwego rushya rwo kwita kubibazo byihanganira.
Immune igenzura (ICIs) ikomeje kuba intandaro, ariko umuhengeri ukurikira urimo antibodiyite za bispecificique zifata sisitemu yumubiri neza. Iyi miti irashobora kwibasira antigene ebyiri zitandukanye icyarimwe, bikongerera ubudahangarwa bw'umubiri kurwanya ikibyimba.
Ku barwayi bo mucyiciro cya mbere, immunotherapy ya neoadjuvant (yatanzwe mbere yo kubagwa) igenda ikurura. Ubushakashatsi bwerekana ko ubu buryo bushobora kugabanya ibibyimba, kubaga byoroshye no kugabanya ibyago byo kongera kubaho.
Nubwo bikiri byinshi mubijyanye nubuvuzi, kuvura selile nka CAR-T birashakishwa kubyimba bikomeye harimo na kanseri yibihaha. Byongeye kandi, inkingo za kanseri yihariye zijyanye na neoantigens yihariye y’umurwayi yerekana amasezerano yo kwirinda gusubira inyuma nyuma yo kubagwa.
Kuyobora sisitemu yubuzima birashobora kuba ingorabahizi. Abashaka kuvura kanseri y'ibihaha hakiri kare, cyane cyane mu turere dufite ubushobozi buhanitse nk'Ubushinwa, gukurikira inzira yubatswe itanga umusaruro mwiza.
Ubu buryo butunganijwe bwerekana amahirwe yo gukira kandi bugabanya ibikorwa bitari ngombwa.
Guhitamo inzira nziza yo kuvura bisaba gusobanukirwa ibyiza nibibi byamahitamo aboneka. Hano haribigereranyo byingamba zambere zikoreshwa muri 2026 kuri kanseri yibihaha hakiri kare.
| Uburyo bwo kuvura | Ibintu by'ingenzi biranga | Abakandida beza | Ibyiza & Ibibi |
|---|---|---|---|
| Kubaga (VATS / Robotics) | Kurandura kumubiri kumubiri ukoresheje tekinoroji yo gutera. | Abarwayi bafite Icyiciro I-II NSCLC n'imikorere myiza y'ibihaha. | Ibyiza: Ibishobora gukira, gukuraho ibibyimba ako kanya. Ibibi: Ibyago byo kubaga, igihe cyo gukira, ntibikwiye kubakandida babaga babi. |
| Ubuvuzi bugamije | Imiti yo mu kanwa yibanda ku ihinduka ryimiterere yihariye (urugero, EGFR, ALK). | Abarwayi bafite ihinduka ryimiterere yabashoferi; bikunze gukoreshwa nkibisanzwe cyangwa neoadjuvant. | Ibyiza: Ingaruka nziza, ubuyobozi bwo munwa, ingaruka nke ugereranije na chemo. Ibibi: Iterambere ryokurwanya mugihe, bisaba kwipimisha genetike. |
| Immunotherapy | Ibiyobyabwenge byongera ubudahangarwa bw'umubiri kurwanya kanseri. | Abarwayi bafite imvugo ndende ya PD-L1 cyangwa nkigice cyo kuvura. | Ibyiza: Ibisubizo biramba, birashoboka kubirekura igihe kirekire. Ibibi: Immune ijyanye nibintu bibi, ibisubizo bihinduka. |
| Antibody-Ibiyobyabwenge (ADCs) | Gutanga intego yo kuvura imiti ya selile kanseri. | Abarwayi bafite indwara zidakira cyangwa imvugo yihariye ya antigen (urugero, TROP2). | Ibyiza: Intego yibanze, ikora neza mubibazo birwanya. Ibibi: Umwirondoro wuburozi bwihariye (urugero, neutropenia), amakuru yigihe kirekire. |
Iri gereranya ryerekana akamaro k'ubuvuzi bwihariye. Nta buvuzi bumwe "bwiza"; guhitamo neza biterwa numwirondoro wibinyabuzima byumuntu hamwe nubuvuzi.
Nubwo hari intambwe ishimishije, ibibazo biracyari mu kurwanya kanseri y'ibihaha. Ubudasa bwo kugera kuvura kanseri y'ibihaha hakiri kare hagati y'imijyi n'icyaro, no hagati y'ibihugu bitandukanye, ni inzitizi ikomeye.
Mugihe AI itanga igisubizo, ukoherezwa kwayo bisaba ibikorwa remezo n'amahugurwa. Uturere twinshi turacyafite ibikoresho byo kubara cyangwa abakozi bafite ubuhanga bwo gusobanura umusaruro wa AI neza. Harimo gukorwa ibishoboka kugirango koroshya ibyo bikoresho no kubishyira mu bikoresho byifashishwa mu turere twa kure.
Ubukangurambaga mu burezi, nk'ubwo bwatangijwe n'ishyirahamwe rishinzwe kurwanya kanseri mu Bushinwa, ni ngombwa. Bagamije gukangurira abaturage akamaro ko gusuzuma no gukuraho imigani ijyanye no gusuzuma kanseri.
Ntabwo byanze bikunze kurwanya ibiyobyabwenge bikomeje kurwanywa bikomeye. Abashakashatsi bahora bashakisha intego nshya hamwe ningamba zo guhuza kugirango bakomeze imbere ya clone yibibyimba. Ibyibandwaho ni uguhindukirira “imiti igabanya ubukana,” aho ubuvuzi buhindurwa mu buryo bushingiye ku kugenzura igihe nyacyo cyo kubyakira.
Ikusanyirizo ryinshi ryamakuru yubuvuzi ritera ubutaha bwo kuvumbura. Ibimenyetso bifatika-byukuri (RWE) byuzuza ibigeragezo byateganijwe mugutanga ubushishozi bwukuntu uburyo bwo kuvura bukora muburyo butandukanye, burimunsi. Aya makuru afite uruhare runini mugutunganya umurongo ngenderwaho no kunoza protocole yubuvuzi.
Kugirango urusheho gufasha abasomyi, dore ibisubizo kubibazo bisanzwe bijyanye kuvura kanseri y'ibihaha hakiri kare muri iki gihe cyubuvuzi.
Nibyo, kanseri y'ibihaha hakiri kare (Icyiciro cya I na II) ifite umuvuduko mwinshi wo gukira, cyane cyane iyo ivuwe no kubagwa ikurikirwa nubuvuzi bukwiye. Ikigereranyo cyimyaka 5 yo kubaho kuri Stage IA NSCLC irashobora kurenga 80-90% hamwe na protocole yubuvuzi bugezweho.
Muri gahunda zicyitegererezo mubushinwa, CT yongerewe ubumenyi bwa CT irashobora kugura amadorari 25. Mu bindi bice byisi, ibiciro biratandukanye bitewe na sisitemu yubuzima, ubwishingizi, hamwe nikoranabuhanga ryihariye rikoreshwa. Mubisanzwe, birashoboka cyane kuruta kugenzurwa gakondo bitewe nukuri.
Ingaruka zinyuranye ziratandukanye kurwego rwibiyobyabwenge. Ubuvuzi bugamije akenshi butera kurwara uruhu, impiswi, cyangwa enzyme yumwijima. Ubudahangarwa bushobora gutera indwara ziterwa n’ubudahangarwa zifata ibihaha, amara, cyangwa glande ya endocrine. ADCs irashobora gutera neutropenia cyangwa umunaniro. Ingaruka nyinshi zishobora gucungwa no kugenzura neza ubuvuzi.
Nibyo, ibitaro byinshi byo mu rwego rwo hejuru mu Bushinwa, nk'ibyo muri Shanghai na Beijing, bifite amashami mpuzamahanga yita ku barwayi b'abanyamahanga. Batanga serivisi zuzuye zirimo ubusemuzi, ubufasha bwa viza, hamwe na gahunda yo kuvura. Ibiciro-byikoranabuhanga hamwe nikoranabuhanga ryateye imbere bituma Ubushinwa bugera ahantu nyaburanga mu bukerarugendo bw’ubuvuzi muri onkologiya.
Umwaka wa 2026 uranga ibihe byingenzi mumateka ya kuvura kanseri y'ibihaha hakiri kare. Ihuriro ryubwenge bwubuhanga, ubuvuzi bwuzuye, nubuvuzi bushya bwahinduye icyahoze ari igihano cyurupfu gihinduka imiyoborere, kandi akenshi ishobora gukira.
Kuva mu bitaro byuzuye bya Shanghai kugeza ku mavuriro y’abaturage afite ibikoresho byo gupima AI, umuryango w’ubuvuzi ku isi wunze ubumwe mu ntego zawo zo kumenya kanseri y'ibihaha hakiri kare no kuyivura neza. Igabanuka rikabije ryibiciro byo gusuzuma no kuboneka uburyo buhanitse bwo kuvura nka ADCs na antibodiyite bispecificique bitanga ibyiringiro bishya kuri miriyoni.
Ku barwayi n'imiryango, ubutumwa burasobanutse: gutahura hakiri kare bikiza ubuzima. Kwakira tekinolojiya mishya no gukurikiza umurongo ngenderwaho ni intambwe zikomeye umuntu ashobora gutera. Mugihe ubushakashatsi bukomeje guhana imbibi, ejo hazaza hitaweho kanseri yibihaha hasa neza kurusha ikindi gihe cyose, bitanga ubuzima burambye hamwe nubuzima bwiza kubanduye bose.
Waba utekereza uburyo bwo gusuzuma, gushakisha ibigo byita ku barwayi, cyangwa gushaka imiti igezweho, ibikoresho n'iterambere biboneka mu 2026 bitanga umusingi ukomeye wo kurwanya iyi ndwara. Komeza umenyeshe, ukore hakiri kare, kandi ukoreshe imbaraga zubuvuzi bugezweho kugirango ubone ibisubizo byiza bishoboka.